In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

Journalists covering COVID-19 faced an extraordinarily challenging task of keeping the public informed in a hyper-politicized climate filled with misinformation and reliance on unsubstantiated ...

Researchers evaluated the efficacy of small molecule drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro.

A panel of expert advisers to the Food and Drug Administration on Nov. 30, recommended authorization of Merck's covid-19 antiviral pill. (Video: Reuters) ...

Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based COVID-19 drug had shown robust efficacy and long-term prevention.

This Sunday, 60 Minutes reports on how a 40-year-old obsessive-compulsive disorder drug, Fluvoxamine, is being tested in the U.S. and Canada to be repurposed and possibly used in the fight against ...

New research finds promising drugs that could be repurposed to treat COVID-19, including medication already approved for cancer and type 2 diabetes.

Hydroxychloroquine and chloroquine have been at the center of debate in recent weeks over which drugs should be used to treat COVID-19. Neither product has strong evidence to support use for this ...

Medicines designed to treat COVID-19 won't be available for months, so doctors are looking to drugs already approved for treating other diseases.